$50.94 -0.68 (%) ISIS Pharmaceuticals Inc - NASDAQ

Nov. 21, 2014 | 04:00 PM

Partner Headlines

  1. ISIS-STAT3 Rx And ISIS-AR Rx Data Presented By AstraZeneca At European Cancer Symposium

    Benzinga | Nov. 20, 2014 | 16:48PM EST
  2. Isis Pharmaceuticals Prices Offering of $425M Of 1.00% Convertible Senior Notes

    Benzinga | Nov. 12, 2014 | 07:02AM EST
  3. Earnings Scheduled For November 7, 2014

    Benzinga | Nov. 7, 2014 | 05:13AM EST
  4. NASDAQ Slides 1.2%; Manitowoc Shares Dip Following Cautious Outlook

    Benzinga | Oct. 10, 2014 | 13:20PM EST
  5. Markets Mixed; Fastenal Earnings Meet Estimates

    Benzinga | Oct. 10, 2014 | 11:26AM EST
  6. Morning Market Movers

    Benzinga | Oct. 10, 2014 | 09:37AM EST
  7. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 10, 2014 | 08:11AM EST
  8. US Stock Futures Signal Lower Start On Wall Street

    Benzinga | Oct. 10, 2014 | 07:20AM EST
  9. Making Money With Charles Payne: 10/08/14

    FoxBusiness | Oct. 9, 2014 | 18:00PM EST
  10. US Stock Futures Mixed Ahead Of Jobless Claims Data

    Benzinga | Oct. 9, 2014 | 07:26AM EST
  11. Isis Pharmaceuticals Earns $18M From GSK For Advancing ISIS-TTR Rx

    Benzinga | Oct. 9, 2014 | 07:02AM EST
  12. GasBuddy: Lowest Gas Prices Of 2014 Unfolding Right Now

    Benzinga | Oct. 7, 2014 | 13:30PM EST
  13. Brent Remains Below $97 On Weak Chinese Data

    Benzinga | Sep. 29, 2014 | 08:48AM EST
  14. Isis Pharmaceuticals Earns $4M from Achaogen For The Initiation Of A Phase 3 Study Of Plazomicin

    Benzinga | Sep. 17, 2014 | 07:27AM EST
  15. Making Money With Charles Payne: 08/29/14

    FoxBusiness | Sep. 3, 2014 | 10:33AM EST
  16. Tensions & Airlines Boost ETFs (ITA, PPA, BA, LMT)

    Benzinga | Aug. 27, 2014 | 15:46PM EST
  17. Companies With 'ISIS' Name Get Unwanted Attention

    FoxBusiness | Aug. 27, 2014 | 15:06PM EST
  18. Isis Pharmaceuticals Finally Breaks Out

    Benzinga | Aug. 27, 2014 | 12:30PM EST
  19. CNBC's Stock Pops & Drops From August 26

    Benzinga | Aug. 26, 2014 | 20:16PM EST
  20. Winners & Losers From Tuesday, August 26

    Benzinga | Aug. 26, 2014 | 16:02PM EST
  21. Fast Money Picks For August 26

    Benzinga | Aug. 25, 2014 | 20:03PM EST
  22. US Stock Futures Up Ahead Of Economic Data

    Benzinga | Aug. 15, 2014 | 07:50AM EST
  23. UPDATE: Laidlow & Co. Initiates Coverage on Isis Pharmaceuticals, Inc. at Buy, Announces $52.00 PT

    Benzinga | Aug. 12, 2014 | 11:34AM EST
  24. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-APO(a) Rx In Patients With High Lp(a)

    Benzinga | Jul. 17, 2014 | 07:01AM EST
  25. Markets Edge Higher; Alcoa Profit Beats Street View

    Benzinga | Jul. 9, 2014 | 10:20AM EST
  26. US Stock Futures Edge Higher Ahead Of ADP Report

    Benzinga | Jul. 2, 2014 | 07:36AM EST
  27. Isis Pharmaceuticals Earns $1M From GSK For Advancing Hepatitis B Virus Program

    Benzinga | Jul. 2, 2014 | 07:00AM EST
  28. Benzinga's Top #PreMarket Losers

    Benzinga | Jun. 27, 2014 | 08:11AM EST
  29. Brent Steady As Iraqi Exports Look Unaffected

    Benzinga | Jun. 26, 2014 | 09:24AM EST
  30. Brent Retreats As Supply Interruption Worries Fade

    Benzinga | Jun. 24, 2014 | 09:34AM EST
  31. Brent Up To $115 As ISIS Moves Toward Baghdad

    Benzinga | Jun. 23, 2014 | 09:10AM EST
  32. Brent Climbs As Iraqi Oil Supplies Are Threatened

    Benzinga | Jun. 20, 2014 | 08:10AM EST
  33. ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart Attack Drug

    Benzinga | Jun. 19, 2014 | 10:27AM EST
  34. Morning Market Movers

    Benzinga | Jun. 19, 2014 | 09:36AM EST
  35. UPDATE: Isis Pharmaceuticals Earns $10M Milestone Payment from Biogen Idec

    Benzinga | Jun. 17, 2014 | 07:02AM EST
  36. US Stock Futures Decline Ahead Of Economic Data

    Benzinga | Jun. 16, 2014 | 07:32AM EST
  37. Isis Pharma Announces Final Phase 2 Data on ISIS-GCGR Rx Showing Significant Reduction in HbA1c for Type-2 Diabetes Patients

    Benzinga | Jun. 16, 2014 | 07:03AM EST
  38. Morning Market Movers

    Benzinga | Jun. 10, 2014 | 09:39AM EST
  39. US Stock Futures Down Ahead Of Wholesale Trade Data

    Benzinga | Jun. 10, 2014 | 07:35AM EST
  40. US Stock Futures Slightly Lower Ahead Of McDonald's Sales Report

    Benzinga | Jun. 9, 2014 | 07:27AM EST
  41. Mid-Day Market Update: Fossil Drops On Downbeat Outlook; SunOpta Shares Gain

    Benzinga | May. 14, 2014 | 12:28PM EST
  42. Mid-Morning Market Update: Markets Open Lower; Macy's Posts Rise In Profit

    Benzinga | May. 14, 2014 | 10:39AM EST
  43. Morning Market Movers

    Benzinga | May. 14, 2014 | 09:49AM EST
  44. Benzinga's Top #PreMarket Gainers

    Benzinga | May. 14, 2014 | 08:07AM EST
  45. US Stock Futures Edge Lower Ahead Of Producer Price Index

    Benzinga | May. 14, 2014 | 07:14AM EST
  46. UPDATE: Piper Jaffray Upgrades ISIS Pharmaceuticals Following Mixed 1Q Results

    Benzinga | May. 7, 2014 | 08:29AM EST
  47. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga | May. 1, 2014 | 07:34AM EST
  48. Mid-Day Market Update: Twitter Drops On Earnings; Pepco Shares Gain

    Benzinga | Apr. 30, 2014 | 13:18PM EST
  49. Isis Pharmaceuticals Shares Dropping Futher After Company released Updated Phase 3 Results Tuesday Afternoon; Shares Down Over 12.5 Percent

    Benzinga | Apr. 30, 2014 | 12:07PM EST
  50. UPDATE: Isis Pharma Offers Updated Results from ISIS-SMN Rx Clinical Studies

    Benzinga | Apr. 29, 2014 | 13:47PM EST
Trading Center